Zavesca

Medicinal product

(Invented) name

Zavesca

Active substance (s)

Migliustatas

Strength

100 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A16AX06, Miglustat

Marketing authorisation holder

Janssen-Cilag International N.V., Belgija

Date of authorisation

2002-11-20

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

capsules, hard	1 vnt.
Migliustatas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
28809	31327	1031327	lizdinė plokštelė	N84		Receptinis	EU/1/02/238/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2002-11-20	Registruotas